Minobose-0.3 Tablets
COMPOSITION – Voglibose 0.3 mg
- An alpha-glucosidase inhibition used for lowering post-prandial glucose
- Delays the absorption of glucose thereby reducing the risk of macrovascular complication
- Has fewer side effects than acarbose and miglitol
- As effective as acarbose in patients with type 2 diabetes who are inadequately controlled with based insulin J Korean med sci 2014 Jan 2013-7
- Adding voglibose to the prescription elicited additive improvement in post-prandial glycemic response
